Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 17 studies | 38% ± 16% | |
peripheral blood | 15 studies | 35% ± 10% | |
brain | 10 studies | 29% ± 9% | |
kidney | 9 studies | 36% ± 10% | |
intestine | 9 studies | 37% ± 17% | |
eye | 9 studies | 32% ± 16% | |
liver | 6 studies | 35% ± 22% | |
bone marrow | 5 studies | 24% ± 7% | |
lymph node | 5 studies | 37% ± 9% | |
pancreas | 4 studies | 52% ± 12% | |
placenta | 4 studies | 35% ± 16% | |
uterus | 4 studies | 42% ± 18% | |
prostate | 4 studies | 25% ± 9% | |
breast | 4 studies | 35% ± 6% | |
adrenal gland | 3 studies | 30% ± 10% | |
skin | 3 studies | 35% ± 12% | |
thymus | 3 studies | 56% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3683.92 | 459 / 459 | 100% | 189.09 | 1118 / 1118 |
esophagus | 100% | 3243.17 | 1445 / 1445 | 100% | 120.83 | 183 / 183 |
liver | 100% | 3334.10 | 226 / 226 | 100% | 132.09 | 406 / 406 |
ovary | 100% | 2939.77 | 180 / 180 | 100% | 163.21 | 430 / 430 |
prostate | 100% | 3770.17 | 245 / 245 | 100% | 160.44 | 502 / 502 |
uterus | 100% | 3099.31 | 170 / 170 | 100% | 179.66 | 459 / 459 |
brain | 100% | 4147.54 | 2641 / 2642 | 100% | 125.77 | 705 / 705 |
thymus | 100% | 3974.24 | 653 / 653 | 100% | 176.20 | 604 / 605 |
lung | 100% | 3503.09 | 577 / 578 | 100% | 162.81 | 1155 / 1155 |
kidney | 100% | 4405.87 | 89 / 89 | 100% | 116.61 | 899 / 901 |
pancreas | 100% | 1578.19 | 327 / 328 | 100% | 151.41 | 178 / 178 |
bladder | 100% | 3269.24 | 21 / 21 | 99% | 140.12 | 500 / 504 |
adrenal gland | 100% | 4713.20 | 258 / 258 | 99% | 125.65 | 228 / 230 |
stomach | 100% | 2646.76 | 359 / 359 | 99% | 117.19 | 283 / 286 |
skin | 100% | 3945.18 | 1808 / 1809 | 99% | 118.93 | 467 / 472 |
intestine | 100% | 3694.32 | 966 / 966 | 98% | 128.71 | 516 / 527 |
adipose | 100% | 3642.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3666.43 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 188.97 | 29 / 29 |
spleen | 100% | 3320.09 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 152.57 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 100.74 | 1 / 1 |
muscle | 100% | 3000.39 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2369.24 | 849 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 2916.21 | 899 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 63.60 | 76 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016925 | Biological process | protein sumoylation |
GO_0006281 | Biological process | DNA repair |
GO_0034605 | Biological process | cellular response to heat |
GO_0086004 | Biological process | regulation of cardiac muscle cell contraction |
GO_0010621 | Biological process | negative regulation of transcription by transcription factor localization |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0032880 | Biological process | regulation of protein localization |
GO_0042308 | Biological process | negative regulation of protein import into nucleus |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_1903169 | Biological process | regulation of calcium ion transmembrane transport |
GO_0030578 | Biological process | PML body organization |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0031334 | Biological process | positive regulation of protein-containing complex assembly |
GO_1902260 | Biological process | negative regulation of delayed rectifier potassium channel activity |
GO_0060021 | Biological process | roof of mouth development |
GO_0050821 | Biological process | protein stabilization |
GO_0045759 | Biological process | negative regulation of action potential |
GO_0043392 | Biological process | negative regulation of DNA binding |
GO_0090204 | Biological process | protein localization to nuclear pore |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005730 | Cellular component | nucleolus |
GO_0005643 | Cellular component | nuclear pore |
GO_0005886 | Cellular component | plasma membrane |
GO_0097165 | Cellular component | nuclear stress granule |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0016605 | Cellular component | PML body |
GO_0031965 | Cellular component | nuclear membrane |
GO_0001741 | Cellular component | XY body |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0005634 | Cellular component | nucleus |
GO_0008134 | Molecular function | transcription factor binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0044388 | Molecular function | small protein activating enzyme binding |
GO_0031386 | Molecular function | protein tag activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0015459 | Molecular function | potassium channel regulator activity |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_1990381 | Molecular function | ubiquitin-specific protease binding |
GO_0044389 | Molecular function | ubiquitin-like protein ligase binding |
Gene name | SUMO1 |
Protein name | Small ubiquitin-related modifier 1 (SUMO-1) (GAP-modifying protein 1) (GMP1) (SMT3 homolog 3) (Sentrin) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C) (Ubiquitin-like protein UBL1) Small ubiquitin like modifier 1 Small ubiquitin-related modifier 1 |
Synonyms | OK/SW-cl.43 SMT3H3 SMT3C UBL1 hCG_1776791 |
Description | FUNCTION: Ubiquitin-like protein that can be covalently attached to proteins as a monomer or a lysine-linked polymer. Covalent attachment via an isopeptide bond to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by E3 ligases such as PIAS1-4, RANBP2 or CBX4. This post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Involved for instance in targeting RANGAP1 to the nuclear pore complex protein RANBP2. Covalently attached to the voltage-gated potassium channel KCNB1; this modulates the gating characteristics of KCNB1 . Polymeric SUMO1 chains are also susceptible to polyubiquitination which functions as a signal for proteasomal degradation of modified proteins. May also regulate a network of genes involved in palate development. Covalently attached to ZFHX3 . . |
Accessions | ENST00000409205.5 ENST00000409627.6 ENST00000409368.5 ENST00000409498.6 B8ZZN6 P63165 ENST00000392245.5 [P63165-1] ENST00000392246.7 [P63165-1] B8ZZJ0 B9A032 B8ZZ67 F8WBI1 ENST00000392244.7 [P63165-2] ENST00000409181.1 ENST00000409712.5 |